Literature DB >> 20427550

A comparison of coronary heart disease event rates among urban Australian Aboriginal people and a matched non-Aboriginal population.

Pamela J Bradshaw1, Helman S Alfonso, Judith Finn, Julie Owen, Peter L Thompson.   

Abstract

BACKGROUND: Age-specific death from cardiovascular disease among Australian Aboriginals is estimated to be four to seven times that of general population, and the major cause of premature death. There is little reliable information on the incidence of coronary heart disease (CHD). This study compares CHD event rates in urban-dwelling Aboriginal people and the general population.
METHODS: The Perth Aboriginal Atherosclerosis Risk Study (PAARS) cohort was assessed at baseline (1998/1999) and 913 participants followed-up to 2006. A comparison group of age-matched, sex-matched and postcode-matched non-Aboriginals (n=3582) were selected from the Perth, Western Australia, Electoral Roll. Electronic record linkage captured prior CHD and first CHD events in both groups. The rates of first CHD events (hospital admission or CHD death) per 1000 person years (PY) and incidence rate ratios (IRR) were calculated.
RESULTS: The event rate for the PAARS population was 14.9 per 1000 PY (95% CI 12.3 to 18.2) versus 2.4 (1.9 to 3.1) for the general population. The IRR was 6.1 (4.5 to 8.4). For Aboriginal men the rate was 15.0 (11.2 to 20.0) versus 3.8 (2.5 to 5.0) per 1000 PY, with age-specific rates being two to five times that of non-Aboriginals. Incidence for Aboriginal women was 15.0 (11.5 to 19.5) versus 1.4 (0.9 to 2.1) with age-specific rates being 8-25 times that of non-Aboriginals.
CONCLUSIONS: Age and sex-specific CHD event rates in urban Aboriginals far exceeded that of a matched general population. Events occurred at a much younger age among the Aboriginal participants and were equally excessive among men and women.

Entities:  

Mesh:

Year:  2010        PMID: 20427550     DOI: 10.1136/jech.2009.098343

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  6 in total

1.  Cardio classics revisited: focus on the role of amlodipine.

Authors:  Alice J Owen; Christopher M Reid
Journal:  Integr Blood Press Control       Date:  2012-01-06

2.  Opportunistic screening to detect atrial fibrillation in Aboriginal adults in Australia.

Authors:  Kylie Gwynne; Yvonne Flaskas; Ciaran O'Brien; Thomas Lee Jeffries; Debbie McCowen; Heather Finlayson; Tanya Martin; Lis Neubeck; Ben Freedman
Journal:  BMJ Open       Date:  2016-11-15       Impact factor: 2.692

3.  Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islander adults.

Authors:  Marc G W Rémond; Simon Stewart; Melinda J Carrington; Thomas H Marwick; Bronwyn A Kingwell; Peter Meikle; Darren O'Brien; Nathaniel S Marshall; Graeme P Maguire
Journal:  BMC Cardiovasc Disord       Date:  2017-08-23       Impact factor: 2.298

4.  Disparities in healthcare utilisation rates for Aboriginal and non-Aboriginal Albertan residents, 1997-2006: a population database study.

Authors:  Helen Chung; Ming Ye; Chris Hanson; Oluwaseun Oladokun; Michael J Campbell; Gordon Kramer; Ordan J Lehmann
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

5.  Validation study of GRACE risk scores in indigenous and non-indigenous patients hospitalized with acute coronary syndrome.

Authors:  Pamela J Bradshaw; Judith M Katzenellenbogen; Frank M Sanfilippo; Michael S T Hobbs; Peter L Thompson; Sandra C Thompson
Journal:  BMC Cardiovasc Disord       Date:  2015-11-16       Impact factor: 2.298

6.  Machine learning risk prediction model for acute coronary syndrome and death from use of non-steroidal anti-inflammatory drugs in administrative data.

Authors:  Girish Dwivedi; Frank M Sanfilippo; Juan Lu; Ling Wang; Mohammed Bennamoun; Isaac Ward; Senjian An; Ferdous Sohel; Benjamin J W Chow
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.